Skip to content

The Benefit of a Deep Cleansing Gel in the Management of Mild to Moderate Truncal Acne

Assessment of the Benefit of a Deep Cleansing Gel Containing Salicylic Acid 2%, Zinc Gluconate 0.2% and Lipohydroxy Acids 0.05% in Patients With Mild to Moderate Truncal Acne: Results From an Exploratory Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05584150
Enrollment
35
Registered
2022-10-18
Start date
2019-10-01
Completion date
2020-11-30
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Keywords

truncal acne

Brief summary

Acne vulgaris is a chronic inflammatory disease, mainly of the face, but also of the trunk. Acne may be caused by internal and external factors. Only a very small amount of data exists concerning truncal acne. The condition affects about 9% of the population worldwide, with 50% of subjects with facial acne also presenting with truncal acne. Until recently, clinicians frequently followed the same therapeutic approach as for facial acne, with treatment adherence remaining an issue. This study assessed assessed the benefit of a cleansing gel containing salicylic acid 2%, zinc gluconate 0.2% and Lipo hydroxy acids (LHA) 0.05%, used daily for 84 days in mild to moderate truncal acne.

Detailed description

For this single center, open label, non-randomized exploratory study, 51 subjects with mild to moderate truncal acne were recruited. The study received ethics committee approval. All subjects provided written informed consent. The investigator evaluated the number of inflammatory, non-inflammatory and total lesions at Baseline, Day 42 and 84. Skin barrier function was appraised via the assessment of transepidermal water loss (TEWL) using a Tewameter® (Courage + Khazaka Electronic GmbH, Germany). Safety was assessed by considering the evaluation of clinical signs and reporting of symptoms, and local adverse reactions. Subjects were asked to gently massage the wet skin of the trunk with the product in the morning and evening for at least 30 seconds, and then thoroughly rinse with tempered water and pat dry.

Interventions

OTHERDeep Cleansing Gel

daily use

Sponsors

Cosmetique Active International
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years

Inclusion criteria

* above 18 years * truncal acne

Exclusion criteria

\- None

Design outcomes

Primary

MeasureTime frameDescription
Investigator global assessmentbaselineScale 0=absent to 5=very serious

Secondary

MeasureTime frameDescription
non-inflammatory lesion countbaselinecount and percentage reduction
total lesion countbaselinecount and percentage reduction
acne severitybaselinescale 0=absent to 5=very severe
inflammatory lesion countbaselinecount and percentage reduction
clinical safetybaselineassessment of clinical signs symptoms and adverse events
subject efficacy perceptionDay 42scale 0=none to 5= very good
subject product perceptionDay 84sacle 0=bad to 5 very good
transepidermal water lossbaselinetewameter assessment

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026